跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ATR-12
首页
药物
ATR-12
ATR-12
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
COMBINATION OF DNA DAMAGING AGENTS AND ATR INHIBITORS FOR USE IN A METHOD FOR TREATING CANCER USING
EP 3355926 B8
申请人: VERTEX PHARMA
优先权: 2015
EP
US
WO
5 件公开
Therapy of neurological inflammatory diseases with (5'-deoxy-5'-adenosyl) cobamamide, recombinant human growth hormone, interleukins IL-1, IL-6, IL-11, epidermal growth factor, and physiotherapy
US 8691790 B2
申请人: BOUCHER JAMES LAYNE
优先权: 2009
US
ISOCYANATE TRIMERISATION CATALYST SYSTEM, A PRECURSOR FORMULATION, A PROCESS FOR TRIMERISING ISOCYANATES, RIGID POLYISOCYANURATE/POLYURETHANE FOAMS MADE THEREFROM, AND A PROCESS FOR MAKING SUCH FOAMS
US 2011201709 A1
申请人: DOW GLOBAL TECHNOLOGIES LLC
优先权: 2009
US
BAF complex modulating compounds and methods of using the same
US 11267809 B2
申请人: UNIV LELAND STANFORD JUNIOR
优先权: 2018
US
药物
反馈